Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Conferences
Guide to authors
Online submissionOnline submission
Permissions
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
naturereprints
About this site
For librarians
 
NPG Resources
Bioentrepreneur
Nature Reviews Drug Discovery
Nature
Nature Medicine
Nature Genetics
Nature Reviews Genetics
Nature Methods
Nature Chemical Biology
news@nature.com
Clinical Pharmacology & Therapeutics
Nature Conferences
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Letters
Nature Biotechnology  21, 1505 - 1508 (2003)
Published online: 16 November 2003; | doi:10.1038/nbt914

Genetically targeted chromophore-assisted light inactivation

Oded Tour1, 2, Rene M Meijer2, David A Zacharias1, 2, 4, Stephen R Adams2 & Roger Y Tsien1, 2, 3

1  Howard Hughes Medical Institute, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0647, USA.

2  Dept. of Pharmacology, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0647, USA.

3  Depts. of Chemistry & Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0647, USA.

4  Present address: Whitney Laboratory, 9505 Ocean Shore Blvd., St. Augustine, Florida 32080, USA.

Correspondence should be addressed to Roger Y Tsien rtsien@ucsd.edu
Studies of protein function would be facilitated by a general method to inactivate selected proteins in living cells noninvasively with high spatial and temporal precision. Chromophore-assisted light inactivation (CALI)1 uses photochemically generated, reactive oxygen species to inactivate proteins acutely, but its use has been limited by the need to microinject dye-labeled nonfunction-blocking antibodies. We now demonstrate CALI of connexin43 (Cx43) and alpha1C L-type calcium channels, each tagged with one or two small tetracysteine (TC) motifs2 that specifically bind the membrane-permeant, red biarsenical dye, ReAsH3, 4. ReAsH-based CALI is genetically targeted, requires no antibodies or microinjection, and inactivates each protein by approx90% in <30 s of widefield illumination. Similar light doses applied to Cx43 or alpha1C tagged with green fluorescent protein (GFP) had negligible to slight effects with or without ReAsH exposure, showing the expected molecular specificity. ReAsH-mediated CALI acts largely via singlet oxygen because quenchers or enhancers of singlet oxygen respectively inhibit or enhance CALI.


MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

REVIEWS
Creating New Fluorescent Probes for Cell Biology
Nature Reviews Molecular Cell Biology Review (01 Dec 2002)

RESEARCH
Activity-dependent regulation of dendritic synthesis and trafficking of AMPA receptors
Nature Neuroscience Article (01 Mar 2004)

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

Figures & Tables
Supplementary info
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Biotechnology
ISSN: 1087-0156
EISSN: 1546-1696
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | Conferences | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2003 Nature Publishing Group | Privacy policy